Waters Corp at Jefferies Global Healthcare Conference in New York Transcript
Okay. We're going to go ahead and kick it off. I'm Tycho Peterson from the life science team. It's my pleasure to have Udit from Waters with us today. So welcome, Udit.
Questions & Answers
Maybe we can just start with a quick look back on 1Q. Obviously, very strong growth in the legacy Waters business. We'll start there, up double digits. Clearly, humming along in the replacement cycle. Just talk about some of the gives and takes, particularly on the biopharma side you saw in the quarter.
Firstly, thank you for having me, Tycho. It's great to be here. A fantastic quarter, double-digit growth. And we saw that this is the legacy business that you're talking about. Instruments still high single digits, LC-MS replacement cycle going very strong.
New products doing extremely well, Alliance IS, TQ Absolute, XR, MRT, nice from new products across the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

